Younger adults · North Carolina
Studies for younger adults in North Carolina
These studies accept adults from 21 or younger and set an upper age limit of 45 or below, so they are aimed at younger adults. Being in the age range does not mean you qualify; screening decides.
49 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersEarly Phase 1
Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking
Duke University
- Location
- Durham, NC
- Eligibility basics
- Ages 18–21
- RecruitingHealthy volunteersPhase 1/Phase 2
Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism
University of North Carolina, Chapel Hill
- Location
- Chapel Hill, NC + 1 other US site
- Eligibility basics
- Ages 18–45
- RecruitingHealthy volunteersPhase 2
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
ENA Respiratory Pty Ltd
- Location
- Raleigh, NC + 5 other US sites
- Eligibility basics
- Ages 18–45
- RecruitingHealthy volunteersPhase 3
Fertilo In Vitro Research Study and Trial
Gameto, Inc.
- Location
- Charlotte, NC + 15 other US sites
- Eligibility basics
- Ages 18–35 · Women only
- RecruitingHealthy volunteers
MiREA-AC for Reducing Problematic Alcohol and Marijuana Use in College Students
mHealth Systems Inc.
- Location
- Charlotte, NC + 1 other US site
- Eligibility basics
- Ages 18–26
- RecruitingPhase 2
Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle
Freya Biosciences ApS
- Location
- Charlotte, NC + 2 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Asheville, NC + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- Asheville, NC + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 1
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
Innoviva Specialty Therapeutics
- Location
- Greenville, NC + 3 other US sites
- Eligibility basics
- Ages 0 mo–18
- RecruitingPhase 3
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
Janssen Research & Development, LLC
- Location
- Chapel Hill, NC + 19 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Janssen Research & Development, LLC
- Location
- Chapel Hill, NC + 11 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Granata Bio Corporation
- Location
- Charlotte, NC + 14 other US sites
- Eligibility basics
- Ages 18–42 · Women only
- RecruitingPhase 3
Brexanolone Lifting Outcomes Of Moms
Lipocine Inc.
- Location
- Chapel Hill, NC + 15 other US sites
- Eligibility basics
- Ages 15–45 · Women only
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Durham, NC + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Sanofi Pasteur, a Sanofi Company
- Location
- Wilmington, NC + 78 other US sites
- Eligibility basics
- Ages 18–45
- RecruitingPhase 3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
GRIN Therapeutics, Inc.
- Location
- Durham, NC + 15 other US sites
- Eligibility basics
- Ages 1 mo–18
- RecruitingPhase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Pfizer
- Location
- Durham, NC + 30 other US sites
- Eligibility basics
- Ages 18–45 · Women only
- RecruitingPhase 1/Phase 2
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Monument Therapeutics Limited
- Location
- Chapel Hill, NC + 14 other US sites
- Eligibility basics
- Ages 17–30
- Recruiting
KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure
SterileCare Inc.
- Location
- Durham, NC + 6 other US sites
- Eligibility basics
- Ages 1 mo–18
- RecruitingPhase 3
Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
Dyne Therapeutics
- Location
- Hillsborough, NC
- Eligibility basics
- Ages 4–18 · Men only
- RecruitingPhase 3
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Vertex Pharmaceuticals Incorporated
- Location
- Charlotte, NC + 2 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2/Phase 3
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis
argenx
- Location
- Chapel Hill, NC + 2 other US sites
- Eligibility basics
- Ages 2–18
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Durham, NC + 34 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingHealthy volunteers
Post-Operative Cesarean Section Cosmesis
Wake Forest University Health Sciences
- Location
- Winston-Salem, NC
- Eligibility basics
- Ages 18–44 · Women only